Scores precomputed nightly
Screener
Filters on financial health, not price action. Every column traces back to a filing.
Quick screens
Financially healthy
Strong finances across profitability, debt and accounting quality.
Cheap & profitable
Making real money, but priced modestly against those profits.
Growing fast
Sales up sharply on last year, without obvious financial strain.
Pays dividends
Returns cash to shareholders and stays financially sound.
Red flags
Companies showing financial distress or unusual accounting. Shown so you can avoid surprises, not as targets.
42 companies
Sign in to export| Company | Health | Price | Market value | P/E | Growth | Margin | F-Score | Flags |
|---|---|---|---|---|---|---|---|---|
| ISRGINTUITIVE SURGICAL INC | 10.0/10 | $394.51+4.14% | $130.22B | 45.59x | 20.5% | 28.4% | 7/8 | |
| NBIXNEUROCRINE BIOSCIENCES INC | 10.0/10 | $158.35+0.35% | $15.58B | 32.55x | 21.4% | 16.7% | 5/8 | |
| INCYINCYTE CORP | 10.0/10 | $120.16-0.33% | $25.15B | 19.55x | 21.2% | 25.0% | 6/8 | |
| BSXBOSTON SCIENTIFIC CORP | 10.0/10 | $51.83+5.11% | $70.54B | 24.39x | 19.9% | 14.4% | 8/8 | |
| BIIBBIOGEN INC. | 9.0/10 | $209.83+0.91% | $32.42B | 25.07x | 2.2% | 13.1% | 6/9 | |
| ZTSZoetis Inc. | 9.0/10 | $73.79+1.56% | $32.21B | 12.05x | 2.3% | 28.2% | 7/9 | |
| EWEdwards Lifesciences Corp | 9.0/10 | $91.60+2.10% | $52.20B | 48.63x | 11.5% | 17.7% | 6/9 | |
| RMDRESMED INC | 9.0/10 | $224.46+5.91% | $32.94B | 21.62x | 9.9% | 26.9% | 8/9 | |
| SYKSTRYKER CORP | 9.0/10 | $315.91-0.47% | $115.67B | 35.63x | 11.2% | 12.9% | 6/9 | |
| GILDGILEAD SCIENCES, INC. | 9.0/10 | $138.36+3.87% | $187.38B | 22.02x | 2.4% | 28.9% | 8/9 | |
| LLYELI LILLY & Co | 9.0/10 | $1180.16-0.47% | $1.09T | 52.80x | 44.7% | 31.7% | 7/9 | |
| MRKMerck & Co., Inc. | 9.0/10 | $135.84+5.65% | $379.74B | 20.80x | 1.3% | 28.1% | 5/9 | |
| JNJJOHNSON & JOHNSON | 9.0/10 | $260.35+0.43% | $662.65B | 24.72x | 6.0% | 28.5% | 4/9 | |
| IDXXIDEXX LABORATORIES INC /DE | 9.0/10 | $529.29-1.80% | $42.68B | 40.28x | 10.4% | 24.6% | 8/9 | |
| ABTABBOTT LABORATORIES | 9.0/10 | $108.33-0.42% | $187.88B | 28.80x | 5.7% | 14.7% | 6/9 | |
| MDTMedtronic plc | 8.7/10 | $94.17+1.15% | $120.55B | 25.11x | 8.4% | 13.2% | 7/8 | |
| DXCMDEXCOM INC | 8.7/10 | $89.75+5.90% | $33.82B | 40.44x | 15.6% | 17.9% | 7/8 | |
| PODDINSULET CORP | 8.7/10 | $150.59+1.65% | $10.38B | 42.01x | 30.7% | 9.1% | 6/8 | |
| REGNREGENERON PHARMACEUTICALS, INC. | 8.7/10 | $803.48+2.44% | $86.58B | 19.22x | 1.0% | 31.4% | 6/8 | |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 8.7/10 | $505.75+1.95% | $138.71B | 35.09x | 8.9% | 32.9% | 6/8 | |
| ALGNALIGN TECHNOLOGY INC | 8.7/10 | $181.31+4.41% | $11.32B | 27.59x | 0.9% | 10.2% | 6/8 | |
| DGXQUEST DIAGNOSTICS INC | 8.0/10 | $240.65+1.88% | $26.32B | 26.53x | 11.8% | 9.0% | 8/9 | |
| BMYBRISTOL MYERS SQUIBB CO | 8.0/10 | $63.83-1.38% | $135.60B | 19.22x | -0.2% | 14.6% | 9/9 | |
| AMGNAMGEN INC | 8.0/10 | $415.21+1.04% | $235.58B | 30.55x | 10.0% | 21.0% | 8/9 | |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 7.3/10 | $228.65+4.31% | $35.23B | 112.28x | 65.2% | 8.4% | 5/8 | |
| THCTENET HEALTHCARE CORP | 7.3/10 | $267.90+2.20% | $25.21B | 10.65x | 3.1% | 11.1% | 5/7 | |
| UHSUNIVERSAL HEALTH SERVICES INC | 7.3/10 | $170.02-2.03% | $10.79B | 7.25x | 9.7% | 8.6% | 7/8 | |
| TECHBIO-TECHNE Corp | 7.3/10 | $72.45+0.21% | $11.31B | 62.17x | -0.4% | 15.0% | 7/8 | |
| ABBVAbbVie Inc. | 7.0/10 | $256.46-1.44% | $452.74B | 107.13x | 8.6% | 6.9% | 8/9 | |
| ZBHZIMMER BIOMET HOLDINGS, INC. | 7.0/10 | $100.65+4.25% | $19.52B | 27.69x | 7.2% | 8.6% | 5/9 | |
| LHLABCORP HOLDINGS INC. | 7.0/10 | $318.13-0.33% | $26.87B | 30.66x | 7.2% | 6.3% | 8/9 | |
| PFEPFIZER INC | 7.0/10 | $26.79+0.11% | $161.24B | 20.75x | -1.6% | 12.4% | 6/9 | |
| BDXBECTON DICKINSON & CO | 7.0/10 | $183.40+3.70% | $52.73B | 31.42x | 8.2% | 7.7% | 6/9 | |
| IQVIQVIA HOLDINGS INC. | 6.0/10 | $236.66-0.85% | $45.41B | 33.39x | 5.9% | 8.3% | 5/8 | |
| OGNOrganon & Co. | 5.0/10 | $13.770.00% | $3.59B | 19.18x | -2.9% | 3.0% | 6/9 | Distress risk |
| BAXBAXTER INTERNATIONAL INC | 5.0/10 | $25.57-0.51% | $13.22B | — | 5.7% | -8.5% | 6/9 | |
| HCAHCA Healthcare, Inc. | 4.7/10 | $404.68-2.10% | $90.97B | 13.41x | 7.1% | 9.0% | 6/8 | Distress risk |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 4.7/10 | $293.35+0.54% | $14.20B | — | -0.9% | -3.6% | 4/7 | |
| MRNAModerna, Inc. | 4.7/10 | $63.32+7.01% | $57.35B | — | -39.9% | -145.2% | 3/9 | |
| DVADAVITA INC. | 4.7/10 | $180.06-2.02% | $12.61B | 16.89x | 6.5% | 5.5% | 6/7 | Distress risk |
| VTRSViatris Inc | 4.0/10 | $16.23-1.22% | $20.02B | — | -3.0% | -24.7% | 5/9 | Distress risk |
| JAZZJazz Pharmaceuticals plc | 3.3/10 | $244.96-4.52% | $15.16B | — | 4.9% | -8.3% | 5/8 | Distress risk |